Jesus Argueta
Overview
Explore the profile of Jesus Argueta including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
153
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sotelo-Ramirez C, Valdes-Tovar M, Zaragoza-Hoyos J, Ortiz-Lopez L, Argueta J, Rosel-Vales M, et al.
Int J Mol Sci
. 2025 Feb;
26(3).
PMID: 39940697
Schizophrenia (SZ) is a chronic disabling mental disorder with high heritability, and several immune-regulating genes have been implicated in its pathophysiology In this study, we investigated the expression of Toll-like...
2.
Sanchez-Florentino Z, Romero-Martinez B, Flores-Soto E, Montano L, Sommer B, Valdes-Tovar M, et al.
Biomedicines
. 2024 Oct;
12(10).
PMID: 39457654
: Schizophrenia (SZ) is a multifactorial chronic psychiatric disorder with a worldwide prevalence of 1%. Altered expression of PLCβ occurs in SZ patients, suggesting alterations in the PLCβ/IP/Ca signaling pathway....
3.
Miranda-Riestra A, Cercos M, Trueta C, Oikawa-Sala J, Argueta J, Constantino-Jonapa L, et al.
Mol Pharmacol
. 2024 Jul;
106(3):107-116.
PMID: 39079719
Melatonin (-acetyl-5-methoxytryptamine) is an indoleamine secreted by the pineal gland during the dark phase of the photoperiod. Its main function is the synchronization of different body rhythms with the dark-light...
4.
Benitez-King G, Argueta J, Miranda-Riestra A, Munoz-Delgado J, Estrada-Reyes R
Mol Pharmacol
. 2024 May;
106(1):3-12.
PMID: 38811168
Melatonin -acetyl-5-methoxytriptamine is an ancient molecule which synchronizes the internal biologic activity with the environmental photoperiod. It is synthesized by the pineal gland during the night and released to the...
5.
Sanchez-Florentino Z, Romero-Martinez B, Flores-Soto E, Serrano H, Montano L, Valdes-Tovar M, et al.
Int J Mol Med
. 2023 Dec;
53(1).
PMID: 38038161
Schizophrenia (SZ) is a multifactorial disorder characterized by volume reduction in gray and white matter, oxidative stress, neuroinflammation, altered neurotransmission, as well as molecular deficiencies such as punctual mutation in...
6.
Estrada-Reyes R, Quero-Chavez D, Alarcon-Elizalde S, Cercos M, Trueta C, Constantino-Jonapa L, et al.
Molecules
. 2022 Sep;
27(17).
PMID: 36080418
Melatonin (MEL), an indolamine with diverse functions in the brain, has been shown to produce antidepressant-like effects, presumably through stimulating neurogenesis. We recently showed that the combination of MEL with...
7.
Valdes-Tovar M, Rodriguez-Ramirez A, Rodriguez-Cardenas L, Sotelo-Ramirez C, Camarena B, Sanabrais-Jimenez M, et al.
World J Psychiatry
. 2022 Mar;
12(2):264-285.
PMID: 35317338
Schizophrenia and bipolar disorder are disabling psychiatric disorders with a worldwide prevalence of approximately 1%. Both disorders present chronic and deteriorating prognoses that impose a large burden, not only on...
8.
Argueta J, Solis-Chagoyan H, Estrada-Reyes R, Constantino-Jonapa L, Oikawa-Sala J, Velazquez-Moctezuma J, et al.
Int J Mol Sci
. 2022 Mar;
23(5).
PMID: 35269623
Melatonin (MEL) is a pleiotropic indolamine that reaches multiple intracellular targets. Among these, MEL binds to calmodulin (CaM) with high affinity. In presence of Ca, CaM binds to CaM-dependent kinase...
9.
Estrada-Reyes R, Quero-Chavez D, Trueta C, Miranda A, Valdes-Tovar M, Alarcon-Elizalde S, et al.
Int J Mol Sci
. 2021 Sep;
22(17).
PMID: 34502152
Major depressive disorder is a disabling disease with the number of affected individuals increasing each year. Current antidepressant treatments take between three to six weeks to be effective with forty...
10.
Solis-Chagoyan H, Dominguez-Alonso A, Valdes-Tovar M, Argueta J, Sanchez-Florentino Z, Calixto E, et al.
Molecules
. 2020 Dec;
25(23).
PMID: 33255515
The pro-oxidant compound okadaic acid (OKA) mimics alterations found in Alzheimer's disease (AD) as oxidative stress and tau hyperphosphorylation, leading to neurodegeneration and cognitive decline. Although loss of dendrite complexity...